Non-canonical activation of VEGFA through TIMM44-dependent mitochondrial remodelling Authors: Tanvi Chaudhary, Sharath Mohan Bhat, Priyadarshika Pradhan, Manjunath B. Joshi, Devanjan Sinha Published: 2026 ABSTRACT Coordination of mitochondrial functional states with nuclear transcriptional programs remain critical for cellular adaptation. Here, we identify mitochondrial protein import capacity as a regulator of redox-dependent signalling in tumour cells. We show that the mitochondrial import motor component TIMM44, which is upregulated in angiogenesis-driven tumours, drives respiratory remodelling without increasing mitochondrial abundance. This mitochondrial reprogramming establishes a redox-competent state that activates ASK1-p38MAPK, resulting in SP1-dependent upregulation of VEGFA independently of HIF stabilization. Importantly, induction of mitochondrial biogenesis via PGC-1α fails to recapitulate this response despite increased active mitochondrial content, demonstrating that abundance of active mitochondria or generic metabolic activation is insufficient to drive this HIF-independent transcription. Collectively, our findings identify mitochondrial protein import process as an active signalling regulator rather than a passive housekeeping role, which links mitochondrial proteostasis to redox-sensitive kinase activation and transcriptional control. This work highlights a non-canonical mitochondrial signalling mechanism through which cells couple organelle remodelling to gene expression programs. Introduction Angiogenesis is a fundamental hallmark of cancer that enables sustained tumour growth and metastatic progression [[1], [2], [3]]. Through secretion of pro-angiogenic factors such as VEGFs, cancer cells stimulate ECs to proliferate, migrate, and assemble into functional vascular networks that supply the growing tumour with oxygen and nutrients [[4], [5], [6]]. Beyond sustaining tumour growth, this vascular expansion facilitates metastatic dissemination and shapes the tumour immune microenvironment [7,8]. Although hypoxia-induced stabilization of hypoxia-inducible factors (HIFs) represents a canonical mechanism driving VEGFA expression [9], emerging evidence indicates that tumour metabolic states can regulate angiogenic programs independently of oxygen availability [10,11]. Classical models of tumour angiogenesis have largely emerged from highly glycolytic tumours. These models emphasize on HIF-dependent responses where metabolic byproducts such as lactate and redox imbalance stabilize HIF1α and promote pro-angiogenic transcriptional programs [[12], [13], [14]]. However, a growing body of evidence indicates that many solid tumours are not exclusively glycolytic. They retain metabolically active mitochondria that are dynamically reprogrammed to function as central regulators of tumour growth, redox homeostasis, and biosynthetic demands [15]. This mitochondrial plasticity is increasingly implicated as a key determinant of tumour fitness [[16], [17], [18]]; yet, how mitochondrial functional states in tumour cells are translated into pro-angiogenic outputs remains poorly understood. Some insights into the metabolic control of angiogenesis have emerged from endothelial biology [19], but how tumour-cell mitochondria, influence angiogenesis is far less understood. A critical determinant of mitochondrial performance is the import of nuclear-encoded proteins through the TIM23-translocase complex [[20], [21], [22]]. TIMM44, a central scaffold of this complex, orchestrates the recruitment of mtHsp70 and associated co-chaperones to drive efficient translocation of precursor proteins into the mitochondrial matrix [23,24]. Although mitochondrial activity has been broadly linked to tumour progression, the role of mitochondrial protein import in actively regulating pro-tumorigenic responses has not been defined. Notably, TIMM44 has been shown to be essential for endothelial cell growth and function [25]; yet its role in tumour cells, particularly in linking mitochondrial respiratory state to signalling mechanisms that govern angiogenesis, remains unexplored. Here, we identify TIMM44 as a key regulator of tumour-induced angiogenesis through its role in mitochondrial protein import–dependent functional remodelling. We show that TIMM44 is upregulated across angiogenesis-driven tumours and that its functional elevation enhances mitochondrial protein import efficiency, augmenting mitochondrial translational capacity and promoting a shift toward oxidative phosphorylation-dependent metabolism. This mitochondrial remodelling induced redox state activates a non-canonical ASK1–p38MAPK axis that drives SP1-dependent transcriptional upregulation of VEGFA independently of HIF stabilization, thereby enhancing angiogenic output. Importantly, this pathway is not recapitulated by TIMM44-independent mitochondrial biogenesis induced via PGC-1α, and is attenuated upon TIMM44 inhibition/depletion, demonstrating specificity of this import-dependent mechanism. Collectively, our findings establish mitochondrial protein import capacity as a regulatory layer driving angiogenic transcription in tumour cells. This work uncovers a previously unrecognized link between mitochondrial proteostasis and pro-angiogenic transcription, providing new insight into how metabolic remodelling is coupled to tumour progression. Results TIMM44 exhibits widespread enrichment across diverse human cancers Mitochondria function not only as bioenergetic centres but also as dynamic hubs that make the tumours stress resilient and help them to sustain unchecked growth [2,26]. Because mitochondrial performance depends heavily on the efficient import of nuclear-encoded proteins, we examined the key element of this machinery, the TIM23-complex, specifically its core scaffold protein TIMM44 which coordinates recruitment of mtHsp70, guiding nuclear-encoded proteins into the matrix [21,27]. TIMM44 was found to be consistently elevated across multiple tumor types. Integrated analysis across pan-cancer transcriptomic datasets (TCGA and GTEx) using UALCAN, TIMER2, and UCSC Xena platforms revealed upregulation of TIMM44 transcripts in several cancer cohorts relative to their normal counterparts. Notably, elevated TIMM44 expression was especially prominent in several solid tumor types, including kidney renal clear cell carcinoma, lung adenocarcinoma, colon adenocarcinoma, Breast cancer invasive carcinoma and cholangiocarcinoma tumours (Fig. S1A). Supporting this observation at the protein level, immunohistochemistry from the Human Protein Atlas revealed strong TIMM44 staining in malignant epithelial compartments, whereas adjacent normal parenchyma displayed only faint expression (Fig. S1B). Enhanced expression of TIMM44 was observed across primary, recurrent, and metastatic tumours in the TCGA pan-cancer cohort (Fig. S1C). Importantly, TIMM44 remained elevated across all tumor grades and stages across different subtypes, reflecting its involvement throughout disease development (Fig. S1D–G). Further analysis of the TCGA-BRCA cohort revealed that TIMM44 expression was highest in primary solid tumours (Fig. S1H), and elevation of the protein levels were found across molecular subclasses (Fig. S1I). Among BRCA cohort, patients with higher TIMM44 expression experienced poorer overall survival, aligning TIMM44 levels with unfavourable clinical outcomes (Fig. S1J). To uncover what drives this overexpression, we examined TIMM44 across genomic copy-number states. A clear gene-dosage effect became evident: tumours with diploid or gain states already exhibited elevated transcripts, while those harbouring high-level amplifications showed the strongest upregulation (Fig. S1K). This relationship suggests that copy-number amplification is a major contributor to TIMM44 overexpression in cancer. Taken together, these findings pointed to TIMM44 as a potentially important mitochondrial regulator of tumor aggressiveness. Because its mRNA levels were highest in gain- and amplification-bearing tumours, we modelled this clinically relevant state using a TIMM44 overexpression system in breast cancer cells (Fig. S1L). This approach allowed us to directly investigate how the gain-of-function of the critical mediator in mitochondrial matrix-directed protein import pathway influence the mitochondrial and metabolic adaptations that sustain rapidly proliferating cancer cells. TIMM44 regulates mitochondrial import capacity to promote organellar remodelling We hypothesized whether elevated TIMM44, acting as a gateway for mitochondrial proteins [28], enhances mitochondrial import capacity thereby remodelling the organelle to support adaption of tumour cells. We first measured the translocation rates utilizing two different recombinant precursor substrates corresponding to matrix-targeted preproteins. Mitochondria isolated from TIMM44OE cells showed higher rate of importing the precursors compared to controls cells (Fig. S1M and N). Expectedly, downregulation of TIMM44 resulted in significant reduction in the mitochondrial localization of key housekeeping chaperones, HSP60 (Fig. S2B and C) and mtHSP70 (Fig. S2D and E) which are commonly used as indicators of impaired mitochondrial protein import [29,30], consistent with the role of TIMM44 in regulating protein import into mitochondrial matrix in the cells tested. To ascertain whether TIMM44-mediated enhancement of import capacity results in a change in the landscape of mitochondrial imported proteins, we performed proteomic profiling of mitochondria-enriched fractions which suggested enhanced mitochondrial proteome remodelling following TIMM44 overexpression. TIMM44OE mitochondria showed a pronounced increase in abundance of multiple nuclear-encoded mitochondrial proteins (Fig. 1A). Particularly, proteins involved in mitochondrial ribosome assembly and gene expression (Fig. 1A and B) were found to be highly upregulated. Consistent with these findings, volcano plot analysis (Fig. 1B) revealed significant enrichment of components of the mitochondrial translational machinery, along with mtDNA maintenance factors including TFAM that is indispensable for mitochondrial DNA (mtDNA) replication, its packaging into nucleoids, and transcription initiation, acting as the key architectural factor that compacts mtDNA into nucleoids and recruits transcriptional polymerases [31,32]. We also observed a coordinated upregulation of proteins associated with mitochondrial protein import, including multiple components of the TIM and TOM complexes, indicative of a broader reinforcement of the import machinery to maintain the translocases stoichiometry [33,34]. This included prominent enrichment of direct TIMM44 interactors, such as mortalin (HSPA9) and PAM16 (Fig. 1C), supporting the higher translocation rates observed in TIMM44OE mitochondria. In addition, other members of inner mitochondrial membrane transport proteins such as OXA1 and TIMM21, which are known for assembly of respiratory subunits [35,36], were also elevated. As a consequence of higher import activity and associated increase in mtDNA maintenance factors, a substantial fraction of proteins involved in oxidative phosphorylation was enriched in TIMM44OE cells, pointing to a functional shift toward enhanced mitochondrial respiration (Fig. 1D–S2A). Approximately 24% of the upregulated proteins mapped to mitochondrial biogenesis and OXPHOS-related pathways (Fig. 1E).Fig. 1Protein-import based upregulation of mitochondria biogenesis.(A) Heatmap of the top 100 most differentially expressed genes selected based on variance. Gene expression values were log2-transformed, Z-score normalized and displayed using a red-to-blue color scale as indicated. Both genes and samples were hierarchically clustered using Euclidean distance. (B) Volcano plot showing differential gene expression between the indicated conditions, with log2 fold change on the x-axis and −log10 (adjusted P value) on the y-axis. Significantly upregulated genes (adjusted P < 0.05, log2 fold change > 1) and downregulated genes (adjusted P < 0.05, log2 fold change < −1) are highlighted in red and blue, respectively. (C) Heatmap depicting the differential expression of mitochondrial import component genes. Expression values were Z-score normalized and shown using a red-to-blue color scale as indicated. Both genes and samples were hierarchically clustered using Euclidean distance. (D) Dot plot illustrating KEGG pathway enrichment analysis performed using the over-representation analysis (ORA) method for both upregulated and downregulated genes in TIMM44OE cells relative to control. Adjusted P values are represented by a color gradient ranging from red to blue, while the size of each dot corresponds to the number of genes enriched in each pathway. (E) Pie chart illustrating enriched upregulated biological processes in the proteomic dataset. (F,G) Western blot analysis of TFAM protein levels in control and TIMM44OE cells, quantified, as fold change over controls. n = 3. Quantification of MB-10 treated sample was performed on S2F. (H) mtDNA copy number analysis calculated as fold change above control, for TIMM44OE, and TIMM44OE MB-10 treated cells, n = 3. (I-K) qRT-PCR analysis of POLRMT, ATAD3A, and MRPL4 mRNA levels in control, TIMM44OE, and TIMM44OE MB-10 treated cells, represented as fold change over controls. n = 3. For panel G-K, data is presented as mean ± s.e.m. Two-tailed Student's t-tests were used for pairwise comparisons between control and TIMM44OE cells, or TIMM44OE and MB-10–treated cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Protein-import based upregulation of mitochondria biogenesis. (A) Heatmap of the top 100 most differentially expressed genes selected based on variance. Gene expression values were log2-transformed, Z-score normalized and displayed using a red-to-blue color scale as indicated. Both genes and samples were hierarchically clustered using Euclidean distance. (B) Volcano plot showing differential gene expression between the indicated conditions, with log2 fold change on the x-axis and −log10 (adjusted P value) on the y-axis. Significantly upregulated genes (adjusted P < 0.05, log2 fold change > 1) and downregulated genes (adjusted P < 0.05, log2 fold change < −1) are highlighted in red and blue, respectively. (C) Heatmap depicting the differential expression of mitochondrial import component genes. Expression values were Z-score normalized and shown using a red-to-blue color scale as indicated. Both genes and samples were hierarchically clustered using Euclidean distance. (D) Dot plot illustrating KEGG pathway enrichment analysis performed using the over-representation analysis (ORA) method for both upregulated and downregulated genes in TIMM44OE cells relative to control. Adjusted P values are represented by a color gradient ranging from red to blue, while the size of each dot corresponds to the number of genes enriched in each pathway. (E) Pie chart illustrating enriched upregulated biological processes in the proteomic dataset. (F,G) Western blot analysis of TFAM protein levels in control and TIMM44OE cells, quantified, as fold change over controls. n = 3. Quantification of MB-10 treated sample was performed on S2F. (H) mtDNA copy number analysis calculated as fold change above control, for TIMM44OE, and TIMM44OE MB-10 treated cells, n = 3. (I-K) qRT-PCR analysis of POLRMT, ATAD3A, and MRPL4 mRNA levels in control, TIMM44OE, and TIMM44OE MB-10 treated cells, represented as fold change over controls. n = 3. For panel G-K, data is presented as mean ± s.e.m. Two-tailed Student's t-tests were used for pairwise comparisons between control and TIMM44OE cells, or TIMM44OE and MB-10–treated cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. We further validated the proteomic profile of TIMM44OE mitochondria that revealed functional enhancement of mitochondrial capacity. We observed that TIMM44OE mitochondria harboured high levels of TFAM (Fig. 3A and B). As a result, the mtDNA copy number in TIMM44OE mitochondria was ∼3-fold higher than the controls (Fig. 1H). MB-10, a highly selective TIMM44 inhibitor, has been shown to disrupt TIM23-dependent protein translocation across the inner mitochondrial membrane [37]. Treatment of TIMM44OE cells with TIMM44 inhibitor MB-10 reversed TFAM levels (Figs. S2F and 1G) and restored mtDNA copy number to those of control cells (Fig. 1H), indicating that the increase in TFAM was a result of increased TIMM44 activity at the import channel, which facilitated the entry of nuclear-encoded factors that subsequently amplified mitochondrial transcription and replication. Therefore, we examined additional components of the mitochondrial gene-expression machinery and found significant upregulation of mitochondrial RNA polymerase (POLRMT) [38] (Fig. 1I), ATAD3A (Fig. 1J), a multifunctional regulator of nucleoid organization, cristae architecture, and mtDNA-protein interactions [[39], [40], [41]] and MRPL4 (Fig. 1K), a core large-subunit mitochondrial ribosomal protein essential for intra-mitochondrial translation. Treatment of TIMM44OE cells with MB-10, reversed the changes induced by TIMM44 (Fig. 1I–K), further supporting the link between TIMM44 activity at import channel and heightened mitochondrial transcriptional-translational output. The results indicate that TIMM44OE promoted enhanced import of mitochondrial proteome resulted in a functionally remodelled organelle with higher mtDNA nucleoids and respiratory capacity. Finally, to assess the clinical relevance of this signature, we analyzed TCGA BRCA datasets using cBioPortal. TIMM44 expression displayed strong positive correlations with POLRMT, MRPL4, and ATAD3A (Fig. S2G–I), indicating that this transcriptional–biogenetic coupling observed experimentally is conserved across patient tumours. Together, these findings demonstrate that TIMM44 gain-of-function augmented the import machinery itself and initiated a transcriptionally active and metabolically reinforced organellar state. TIMM44 couples mitochondrial protein import to enhanced respiratory capacity To determine whether TIMM44-driven mitochondrial remodelling translated into functional bioenergetic consequences, we next examined the mitochondrial respiratory performance. The TIMM44OE cells showed minimal acidification of the extracellular media (Fig. S3A), overtime compared to controls and expectedly, exhibited much lower LDH expression (Fig. S3B), indicating a predominant reliance on mitochondrial respiration. We therefore, assessed the abundance of mitochondrial respiratory complex subunits and observed that TIMM44OE cells showed significant upregulation of the nuclear-encoded components NDUFB8, UQCR2, and COXII, representing key subunits of Complexes I, III, and IV, respectively (Fig. 2A–C, S3C), which further validated the proteomic results. In parallel, mitochondrial DNA-encoded components ND1 and CYTB, representing Complexes I and III respectively, showed increased transcript abundance (Fig. 2D and E), Correlation analyses in TCGA BRCA datasets further showed strong associations between TIMM44 and Complex I & III subunits (Fig. S3H and I) reflecting coordinated activation of respiratory chain components across nuclear and mitochondrial genomes, and aligning with our previous observations on enhanced nuclear-protein import and organeller transcription/translation output. Pharmacologic inhibition with MB-10 fully restored ND1 and CYTB expression to control levels (Fig. 2D and E), demonstrating that their induction is tightly coupled to TIMM44-dependent import activity. Analysis of the mitochondrial proteome indicated cumulative upregulation of multiple subunits across all respiratory complexes in TIMM44OE cells (Fig. 2F). To assess the physiological consequences of this molecular rewiring, we performed respirometry analysis (Fig. 2G). TIMM44 overexpression broadly enhanced mitochondrial function, increasing basal (Fig. 2H) and maximal respiration (Fig. S3D), along with better spare respiratory capacity (Fig. 2I). The increase in mitochondrial respiration was mainly due to enhanced Complex I activity (Fig. S3E) and better Complex I-III transfer kinetics (Fig. S3F), along with parallel increase in Complex IV activity (Fig. S3G). The cells showed a shift towards on oxidative metabolism as indicated by very low non-mitochondrial respiration (Fig. 2J). Although the proton leak in TIMM44OE mitochondria was high (Fig. 2K), probably due to high Complex I and Complex III activity, their coupling efficiency remained unchanged (Fig. 2L), indicating intact ETC performance. In fact, the cells showed higher RCR (Fig. 2M), indicating their better capability to couple oxygen consumption with ATP production (Fig. 2N). Hence, the TIMM44OE mitochondria possessed better capability for ATP production and this functional enhancement correlated with higher intracellular ATP (Fig. 2O). Treatment with MB-10 normalized the ATP to levels equivalent to controls. However, these changes were due to enhancement of functional capacity of individual mitochondria rather than an increase in active mitochondrial content (Fig. 2P). The membrane potential (Fig. 2Q) and mitochondrial morphology (Fig. S3J) was also preserved, suggesting uncompromised structural integrity. An unchanged PGC-1α expression (Fig. S3K and L) in TIMM44OE cells supported that the respiratory activation arose from enhanced import-driven mitochondrial transcription/translation rather than canonical biogenesis. The TIMM44OE cells also showed a higher NAD+/NADH ratio (Fig. 2R), indicating utilization of these electron donors in a robust Complex I dependent respiration. Collectively, these findings position TIMM44 as a potent amplifier of respiratory capacity through mitochondrial remodelling.Fig. 2Enhancement of mitochondrial respiratory capacity by TIMM44-induced biogenesis.(A) Immunoblot showing protein levels of representative nuclear-encoded respiratory chain subunits NDUFB8 (Complex I), COXII (Complex IV) and UQCR2 (Complex III) across control and TIMM44OE cells. (B, C) Densitometric quantification of NDUFB8 and UQCR2 protein levels normalized to loading control and represented as fold change over control, n = 3. (D, E) qRT-PCR analysis of mitochondrial DNA-encoded respiratory subunits ND1 and CYTB across control, TIMM44OE, and TIMM44OE MB-10–treated cells, calculated as fold change over controls, n = 3. (F) Scatter plot derived from mitochondrial proteomic analysis showing relative abundance of respiratory chain subunits across mitochondrial complexes. (G-N) Seahorse XF mitochondrial stress assay for control and TIMM44OE cells, normalized per μg of protein (Oligo- Oligomycin, Rot- Rotenone, Ant- Antimycin). The following respiratory parameters were calculated - basal and maximal respiration, spare respiratory capacity, non-mitochondrial respiration, coupling efficiency, respiratory control ratio (RCR), and ATP production, n = 3. (O) Intracellular ATP levels across control, TIMM44OE, and TIMM44OE MB-10-treated cells, n = 3. (P, Q) NAO- and TMRE-based analysis of mitochondrial mass and membrane potential, n = 4. (R) NAD+/NADH ratio in control, TIMM44OE, and TIMM44OE MB-10-treated cells, n = 3 All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells, or between TIMM44OE and MB-10-treated TIMM44OE cells. Statistical significance was determined using two-tailed Student's T-tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.Fig. 3Alteration in redox-state by the respiration competent mitochondria.(A) Quantification of MitoSOX fluorescence intensity in control and TIMM44OE cells, n = 4. (B) Quantification of intracellular GSSG levels represented as fold change relative to control cells n = 3. (C-H) Immunoblot analysis and quantification of mitochondrial and cytosolic antioxidant components, including glutamate-cysteine ligase (GCL) (C, D), PRX3 (E, F) and GSK3β (G, H), with corresponding densitometric quantifications represented as fold-change over control, n = 3. (I, J) qRT–PCR analysis of c-MYC (I) and CDK1 (J) transcript levels calculated as fold change over control, n = 3. (K-M) qRT–PCR analysis of PIN1, CDC37, and PPAN expression in control, TIMM44OE, and MB-10–treated cells, calculated as fold change over control, n = 3. All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells, and TIMM44OE and MB-10–treated TIMM44OE cells. Statistical significance was determined using two-tailed Student's t-tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Enhancement of mitochondrial respiratory capacity by TIMM44-induced biogenesis. (A) Immunoblot showing protein levels of representative nuclear-encoded respiratory chain subunits NDUFB8 (Complex I), COXII (Complex IV) and UQCR2 (Complex III) across control and TIMM44OE cells. (B, C) Densitometric quantification of NDUFB8 and UQCR2 protein levels normalized to loading control and represented as fold change over control, n = 3. (D, E) qRT-PCR analysis of mitochondrial DNA-encoded respiratory subunits ND1 and CYTB across control, TIMM44OE, and TIMM44OE MB-10–treated cells, calculated as fold change over controls, n = 3. (F) Scatter plot derived from mitochondrial proteomic analysis showing relative abundance of respiratory chain subunits across mitochondrial complexes. (G-N) Seahorse XF mitochondrial stress assay for control and TIMM44OE cells, normalized per μg of protein (Oligo- Oligomycin, Rot- Rotenone, Ant- Antimycin). The following respiratory parameters were calculated - basal and maximal respiration, spare respiratory capacity, non-mitochondrial respiration, coupling efficiency, respiratory control ratio (RCR), and ATP production, n = 3. (O) Intracellular ATP levels across control, TIMM44OE, and TIMM44OE MB-10-treated cells, n = 3. (P, Q) NAO- and TMRE-based analysis of mitochondrial mass and membrane potential, n = 4. (R) NAD+/NADH ratio in control, TIMM44OE, and TIMM44OE MB-10-treated cells, n = 3 All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells, or between TIMM44OE and MB-10-treated TIMM44OE cells. Statistical significance was determined using two-tailed Student's T-tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Alteration in redox-state by the respiration competent mitochondria. (A) Quantification of MitoSOX fluorescence intensity in control and TIMM44OE cells, n = 4. (B) Quantification of intracellular GSSG levels represented as fold change relative to control cells n = 3. (C-H) Immunoblot analysis and quantification of mitochondrial and cytosolic antioxidant components, including glutamate-cysteine ligase (GCL) (C, D), PRX3 (E, F) and GSK3β (G, H), with corresponding densitometric quantifications represented as fold-change over control, n = 3. (I, J) qRT–PCR analysis of c-MYC (I) and CDK1 (J) transcript levels calculated as fold change over control, n = 3. (K-M) qRT–PCR analysis of PIN1, CDC37, and PPAN expression in control, TIMM44OE, and MB-10–treated cells, calculated as fold change over control, n = 3. All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells, and TIMM44OE and MB-10–treated TIMM44OE cells. Statistical significance was determined using two-tailed Student's t-tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Mitochondrial hyperactivity via TIMM44 promotes redox imbalance Enhanced electron transport chain activity through Complex I and III in TIMM44OE cells suggest TIMM44-driven mitochondrial remodelling may alter intracellular redox homeostasis. Complex I and Complex III are one of the prime generators of mtROS [[42], [43], [44]]. Indeed, increased respiratory activity through these complexes was accompanied by enhanced mitochondrial superoxide production in TIMM44OE cells (Fig. 3A), indicating the presence of a persistent mitochondrial oxidative burden. To determine whether this altered redox state coupled with lower NADH pool impacts cellular antioxidant buffering capacity, we next examined glutathione homeostasis. TIMM44OE cells exhibited depletion of reduced glutathione (GSH) together with accumulation of oxidized glutathione (GSSG) (Fig. 3B), consistent with a shift toward a more oxidized intracellular environment. In agreement with impaired glutathione maintenance, GCL, the rate-limiting enzyme governing glutathione synthesis, was found downregulated in TIMM44OE cells (Fig. 3C and D). However, the mitochondrial peroxiredoxin PRX3, along with GSK3β (a redox-responsive kinase linked to stress-induced apoptosis and mitophagy), remained largely unaltered (Fig. 3E–H); thereby, generating a ROS-rich yet non-lethal environment. This triggered the canonical ROS-responsive transcriptional amplifier, c-MYC [45,46] which was strongly upregulated in TIMM44OE cells, and its expression returned to baseline following MB-10 (Fig. 3I). CDK1, a key MYC-cooperative regulator of cell-cycle progression [47], was similarly elevated and MB-10 sensitive (Fig. 3J). Beyond MYC and CDK1, TIMM44 overexpression induced a broader redox-responsive oncogenic factors comprising of PIN1 (Fig. 3K), a ROS-activated prolyl isomerase that stabilizes MYC [48]; CDC37 (Fig. 3L), an HSP90 co-chaperone required for the maturation of multiple oncogenic kinases [49]; and PPAN (Fig. 3M), a MYC-regulated factor essential for ribosome biogenesis and growth [50]. All these transcription factors reduced to controls levels upon MB-10 treatment. cBioPortal analyses in TCGA-BRCA further revealed strong positive correlations between TIMM44 and PIN1, CDC37 and PPAN (Fig. S4A–C), demonstrating that this TIMM44-linked redox signature is observed across human tumours. Consistent with activation of these mitogenic factors, TIMM44OE cells proliferated faster than the control cells (Fig. S4D). In summary, TIMM44-dependent mitochondrial activation generated a redox-competent state that supported MYC-dependent cell proliferation. TIMM44 primes tumor cells for angiogenic output Frequently, proliferative signalling acts as a trigger for a pro-angiogenic response in rapidly dividing epithelial cell populations and TIMM44 has recently been associated with maintenance of endothelial cell proliferation and migration [25]. We asked the question whether this TIMM44-mediated mitochondrial remodelling rewires the proliferating tumour cells to drive a pro-angiogenic transcriptional output. We tested the expression of VEGFA, a canonical and rate-limiting pro-angiogenic factor in TIMM44OE cells and found a marked increase in VEGFA transcript and protein abundance (Fig. 4A–C). A similar increase in VEGFA expression was found when TIMM44 was elevated in two other breast cancer cell lines T-47D and ZR-75-1 (Fig. S5A and B). A positive correlation was also observed between TIMM44 and VEGFA in cBioPortal datasets (Fig. S5C)Fig. 4TIMM44 expression is associated with increased VEGF expression(A, B) Western blot analysis of VEGFA protein expression in TIMM44OE MCF-7 cells, quantified as fold change over control (B), n = 3. (C) qRT-PCR analysis of VEGFA transcripts in TIMM44OE cells with or without MB-10 treatment, represented as fold change over controls. n = 3. (D, E) Immunoblot analysis of VEGFA protein levels in TIMM44OE cells following MB-10 treatment, further quantified as fold change over control (E), n = 3. Coomassie Brilliant Blue (CBB)-stained post-transfer gels were used as the loading control for MB-10-treated samples due to MB-10-induced disruption of F-actin (F-H) Western blot quantification of pan-AKT and ERK1/2 protein levels in control and TIMM44OE cells, further analyzed densitometrically (G, H), n = 3. (I, J) qRT-PCR–based analysis of ANGPT1 and ANGPT2 expression, represented as fold change over controls, n = 3. All data is presented as mean ± s.e.m. Two-tailed Student's t-tests were used for pairwise comparisons between control and TIMM44OE cells, or TIMM44OE and MB-10–treated cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. TIMM44 expression is associated with increased VEGF expression (A, B) Western blot analysis of VEGFA protein expression in TIMM44OE MCF-7 cells, quantified as fold change over control (B), n = 3. (C) qRT-PCR analysis of VEGFA transcripts in TIMM44OE cells with or without MB-10 treatment, represented as fold change over controls. n = 3. (D, E) Immunoblot analysis of VEGFA protein levels in TIMM44OE cells following MB-10 treatment, further quantified as fold change over control (E), n = 3. Coomassie Brilliant Blue (CBB)-stained post-transfer gels were used as the loading control for MB-10-treated samples due to MB-10-induced disruption of F-actin (F-H) Western blot quantification of pan-AKT and ERK1/2 protein levels in control and TIMM44OE cells, further analyzed densitometrically (G, H), n = 3. (I, J) qRT-PCR–based analysis of ANGPT1 and ANGPT2 expression, represented as fold change over controls, n = 3. All data is presented as mean ± s.e.m. Two-tailed Student's t-tests were used for pairwise comparisons between control and TIMM44OE cells, or TIMM44OE and MB-10–treated cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. To test whether the elevation of VEGFA levels specifically stemmed from increased mitochondrial import capacity, we inhibited TIMM44 activity at the import channel using MB-10, which significantly caused a reduction in VEGFA levels (Fig. 1D and E), indicating a functional correlation between mitochondrial import capacity and VEGFA expression. VEGFA frequently functions in an autocrine loop to enhance tumor cell proliferation by triggering downstream molecules such as ERK and AKT [51,52]. Both ERK1/2 and pan-AKT were found to be upregulated in TIMM44OE cells (Fig. 4F–H). These observations also aligned with the pattern in cBioPortal datasets where TIMM44-high tumours displayed strong correlation with MAP2K2 (MEK2) (Fig. S5D), the principal upstream activators of ERK. The heightened angiogenic output extended beyond VEGFA, as TIMM44-remodelled mitochondria induced both ANGPT1 and ANGPT2 (Fig. 4I and J), that serve as critical modulators of endothelial activation and vessel stabilization. ANGPT1, which promotes vessel maturation [53], was modestly upregulated (Fig. 4J), whereas ANGPT2 known to facilitate sprouting and vascular permeability [54,55] showed a more pronounced induction (Fig. 4I). This suggests that TIMM44OE cells shift toward a pro-sprouting, pro-remodelling angiogenic profile typically associated with aggressive tumours. Together, these results indicate towards a potential link between mitochondrial translocase activity and endothelial growth signaling from tumor cells, positioning TIMM44 as a central regulator. TIMM44-driven angiogenesis occurs independently of HIF stabilization The robust dependence of TIMM44 expressing cells on aerobic respiration culminated in increased VEGFA production. Typically, such strong VEGFA induction is initiated by HIF-1α which is the canonical regulator of VEGFA under hypoxia and metabolic stress. We therefore, first asked whether TIMM44 engages this pathway. Surprisingly, HIF-1α protein levels were significantly reduced in TIMM44OE cells (Fig. 5B, S6A), indicating that VEGFA activation probably proceeds through a HIF-independent mechanism and necessitating identification of alternative transcriptional regulators. Hence, we systematically profiled for other transcription factors that could potentially bind VEGFA promoter and induce its expression. We did not observe any change in the levels of STAT3 [56] (Fig. 5C–S6B) and AP1 levels [57] (Fig. 5D). In contrast, SP1 transcript levels were markedly increased in TIMM44OE cells and inhibition of TIMM44 by MB-10 significantly reduced its levels (Fig. 5E). To test whether this elevated SP1 was responsible for VEGFA induction, we depleted the SP1 transcript levels using RNAi which resulted in substantial reduction in VEGFA protein levels compared to TIMM44OE alone (Fig. 5F–S6C) highlighting its role as an essential mediator of this transcriptional program.Fig. 5Mitochondrial ROS non-canonically induces VEGFA expression.(A) Schematic summarizing the major drivers of VEGFA expression. (B) Immunoblot analysis of HIF1α protein levels in control and TIMM44OE cells. (C) Immunoblot analysis of STAT3 protein levels. (D, E) qRT-PCR analysis of AP-1 (D) and SP1 (E) transcript levels calculated as fold change over control, n = 3. (F) Immunoblot analysis of VEGFA protein levels following shRNA-mediated SP1 depletion in TIMM44OE cells. (G) Immunoblot analysis of COX-2 protein expression. (H) Immunoblot analysis of VEGFA protein levels following pharmacological inhibition of COX-2 by Celecoxib. (I) qRT-PCR analysis of EGFR transcript abundance, calculated as fold change over control, n = 3. (J, K) Immunoblot analysis of total PTEN (J) and oxidized PTEN (K). (L) Levels of pAKTSer473 estimated using immunoblotting. (M, N) Immunoblot analysis of thioredoxin (TRX) redox states under reducing (M) and non-reducing conditions (N) showing the oxidation states of the protein. (O) Immunoblot analysis of ASK1 protein levels. (P) Immunoblot analysis of p38MAPK phosphorylation status. (Q) qRT-PCR analysis of SP1 transcript levels in TIMM44OE cells treated with p38MAPK-IN-1 inhibitor, calculated as fold change over control, n = 3. (R) Immunoblot analysis of VEGFA protein levels following pharmacological inhibition of p38MAPK by p38MAPK-IN-1 inhibitor. (S-U) Immunoblot analysis of VEGFA, ASK1 AND p38Mapk protein levels in TIMM44sh cells. All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells and TIMM44OE and MB-10–treated TIMM44OE cells or TIMM44OE cells and TIMM44OE cells transfected with SP1 siRNA/treated with an inhibitor (p38MAPK-IN-1/celecoxib). Statistical significance was determined using two-tailed Student's t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Mitochondrial ROS non-canonically induces VEGFA expression. (A) Schematic summarizing the major drivers of VEGFA expression. (B) Immunoblot analysis of HIF1α protein levels in control and TIMM44OE cells. (C) Immunoblot analysis of STAT3 protein levels. (D, E) qRT-PCR analysis of AP-1 (D) and SP1 (E) transcript levels calculated as fold change over control, n = 3. (F) Immunoblot analysis of VEGFA protein levels following shRNA-mediated SP1 depletion in TIMM44OE cells. (G) Immunoblot analysis of COX-2 protein expression. (H) Immunoblot analysis of VEGFA protein levels following pharmacological inhibition of COX-2 by Celecoxib. (I) qRT-PCR analysis of EGFR transcript abundance, calculated as fold change over control, n = 3. (J, K) Immunoblot analysis of total PTEN (J) and oxidized PTEN (K). (L) Levels of pAKTSer473 estimated using immunoblotting. (M, N) Immunoblot analysis of thioredoxin (TRX) redox states under reducing (M) and non-reducing conditions (N) showing the oxidation states of the protein. (O) Immunoblot analysis of ASK1 protein levels. (P) Immunoblot analysis of p38MAPK phosphorylation status. (Q) qRT-PCR analysis of SP1 transcript levels in TIMM44OE cells treated with p38MAPK-IN-1 inhibitor, calculated as fold change over control, n = 3. (R) Immunoblot analysis of VEGFA protein levels following pharmacological inhibition of p38MAPK by p38MAPK-IN-1 inhibitor. (S-U) Immunoblot analysis of VEGFA, ASK1 AND p38Mapk protein levels in TIMM44sh cells. All data are presented as mean ± SEM. Comparisons were performed between control and TIMM44OE cells and TIMM44OE and MB-10–treated TIMM44OE cells or TIMM44OE cells and TIMM44OE cells transfected with SP1 siRNA/treated with an inhibitor (p38MAPK-IN-1/celecoxib). Statistical significance was determined using two-tailed Student's t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. SP1 is also known to engage the COX-2 promoter [58], that establishes a feed-forward regulatory loop that amplifies the transcriptional output. Consistent with this idea, COX-2 expression was significantly elevated in TIMM44OE cells (Fig. 5G–S6D). Pharmacological inhibition of COX-2 activity using Celecoxib resulted in a concomitant decrease in VEGFA expression (Fig. 5H–S6E), indicating that SP1 and COX-2 function cooperatively to sustain VEGFA induction. In search for upstream mediators linking mitochondrial hyperactivity with SP1 activation, we assessed for different kinase axes. EGFR-PI3K-AKT axis forms one of the predominant pathways that activate SP1, however, we did not find any change in EGFR levels [59] (Fig. 5I). This led us to probe whether PI3K [10] was activated by redox-inactivated PTEN, since TIMM44OE cells exhibited elevated mitochondrial ROS as a consequence of ETC hyperactivation and disproportionate antioxidant buffering. PTEN levels were found stable under reducing conditions (Fig. 5J–S6F), and non-reducing conditions did not indicate any change between the oxidized and reduced forms under TIMM44OE condition (Fig. 5K–S6G) thereby, ruling out the involvement of this pathway. To further exclude a contribution of canonical PI3K-AKT-mTOR-dependent translational control to VEGFA upregulation [60], we examined the levels of pAKTSer473 and phosphorylation status of 4EBP1, a key downstream effector of mTOR signalling. Notably, we found reduced accumulation of pAKTSer473 in TIMM44OE cells (Fig. 5L–S6H) and the levels of phosphorylated 4EBP1 in these cells remained unchanged compared to controls (Fig. S6I and J), indicating that enhanced VEGFA expression is unlikely to arise from increased cap-dependent translation. Finally, we examined the TRX-ASK1-p38MAPK pathway [61,62] which indicated presence of high levels of TRX under reducing conditions (Fig. 5M–S6K), a significant proportion of which was in the oxidized form as revealed by non-reducing gels (Fig. 5N–S6L). This indicated an oxidative shift that disrupts TRX-mediated inhibition of ASK1. Consistent with this relief of repression, ASK1 protein levels increased (Fig. 5O–S6M), and p38MAPK showed robust activation (Fig. 5P–S6N), regulating SP1 transcriptional activity [63]. Pharmacological inhibition of p38MAPK by p38MAPK-IN-1 led to a marked reduction in SP1 levels (Fig. 5Q) and VEGFA protein abundance (Fig. 5R and S6O), demonstrating that p38 activation is functionally necessary for TIMM44-driven SP1-mediated VEGFA upregulation and, p38MAPK acts as a connecting link between TIMM44-promoted redox signaling to VEGFA induction in TIMM44OE cells. Importantly, loss-of-function analysis by TIMM44 knockdown further reinforced the specificity of this pathway. TIMM44sh resulted in reduced VEGFA (Fig. 5S–S6P) and ASK1(Fig. 5T–S6Q) protein levels, while p38MAPK (Fig. 5U–S6R) expression remained largely unchanged, suggesting that disruption of mitochondrial protein import prevented the observed activation of the ASK1-p38MAPK axis. To further examine whether this effect is a consequence of a general increase in mitochondrial activity or specific to TIMM44-mediated mitochondrial hyperactivity, we induced mitochondrial biogenesis through glycerol-mediated upregulation of PGC-1α (Fig. S6T and S6U). This was accompanied by a measurable increase in mitochondrial mass, as assessed by NAO staining (Fig. S6S). However, despite a clear increase in mitochondrial biogenesis (Fig. S6T and S6U), levels of ASK1 (Fig. S6T and S6V), p38MAPK (Fig. S6T and S6W) remained unchanged. In contrast, HIF-1α protein levels were elevated following PGC-1α induction (Fig. S6T and S6X), suggesting that generalized mitochondrial biogenesis preferentially engages canonical hypoxia-responsive signalling. Collectively, these results demonstrate that activation of this TIMM44-mediated pro-angiogenic response is not a consequence of increased mitochondrial metabolic activation. Instead, it is driven by TIMM44-dependent functional remodelling of mitochondria, highlighting mitochondrial protein import capacity mediated organellar hyperactivation as a critical determinant of this non-canonical angiogenic program. TIMM44 activates endothelial sprouting and neovascularization To further ascertain whether the tumour cells producing this non-canonically induced VEGFA, are functionally capable of promoting neovascularization, we performed a 3D endothelial spheroid sprouting assay. Endothelial spheroids cultured in standard endothelial growth medium (EGM) displayed only minimal sprouts, reflecting their baseline angiogenic behaviour. In contrast, conditioned media (CM) collected from TIMM44OE breast cancer cells triggered a markedly more robust sprouting response than CM from control cells (Fig. 6A). Even when diluted to 75%, 50%, or 25% with EGM, the TIMM44OE CM consistently triggered far more sprouting than control CM (Fig. 6A), indicating the presence of potent pro-angiogenic factors released by TIMM44-high tumour cells. Quantitative measurements reinforced these observations since spheroids treated with TIMM44OE CM displayed significantly more sprouts (Fig. 6B–E), longer average sprout lengths (Fig. 6F–I) at all dilutions. Additionally, the sprout diameter, a reflection of endothelial cord stability and lumen-forming potential, was substantially enhanced in spheroids exposed to higher CM concentrations (Fig. 6A lower panel). Notably, the average spheroid diameter itself was also significantly increased in spheroids treated with 50% and 100% CM derived from TIMM44OE cells (Fig. 6J–K), indicating augmented endothelial growth and structural expansion under pro-angiogenic conditions. IL-6, used as a positive control for angiogenic stimulation, produced a similar response, supporting the strong angiogenic potency of TIMM44-driven secreted factors. In parallel, TIMM44OE CM also increased HUVEC proliferation overtime, relative to control CM at all tested dilutions (Fig. 6L), reinforcing the idea that TIMM44-dependent mitochondrial signalling drives a paracrine secretory program that supports multiple endothelial behaviours essential for angiogenesis. Finally, to assess whether the lowering of VEGFA levels translated to changes in endothelial growth phenotypes, we exposed the HUVEC cells to CM media derived from either SP1RNAi, Celecoxib or p38MAPK-IN-1 treated TIMM44OE cells. Under all the above treatment conditions, the proliferative capacity of the endothelial cells was found to be weaker than the ones exposed to CM from untreated TIMM44OE controls (Fig. 6M).Fig. 6TIMM44-high tumour cells promote endothelial growth and proliferation.(A) Endothelial spheroid sprouting assay performed using conditioned media (CM) from control and TIMM44OE cells at CM:ECGM ratios of 25:75, 50:50, 75:25, and 100:0, ECGM alone was used as the baseline control, while IL-6 + ECGM served as a positive control. (B-E) Quantitative analysis of endothelial sprout number. For each CM:ECGM ratios, the number of endothelial spheroids analyzed (n) was as follows: 25:75 control (n = 7), TIMM44OE (n = 6); 50:50 control (n = 7), TIMM44OE (n = 10); 75:25 control (n = 4), TIMM44OE (n = 5); 100:0 control (n = 4), TIMM44OE (n = 5). (F-I) Quantitative analysis of average sprout length. The number of endothelial spheroids analyzed (n) for each CM:ECGM ratio was as follows; (average sprout length represents the mean value per spheroid) 25:75 control (n = 6), TIMM44OE (n = 6); 50:50 control (n = 7), TIMM44OE (n = 10); 75:25 control (n = 4), TIMM44OE (n = 4); 100:0 control (n = 2), TIMM44OE (n = 4).(J, K) Quantitative analysis of endothelial sprout diameter. The number of endothelial spheroids analyzed (n) was as follows; n = 5 (control) and 8 (TIMM44OE) for 50:50, and n = 3 (control) and 5 (TIMM44OE) for 100:0. Statistical significance of all quantifications, unless specifically mentioned, was assessed using two-tailed Student's t-tests comparing control and TIMM44OE independently for each CM:ECGM ratio (25:75, 50:50, 75:25, and 100:0). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (L) Endothelial cell proliferation assessed over a 5-day period following conditioned media treatment at the indicated ratios (n = 3). The sample with maximum growth rate was set at 100% and used for normalization of the rest (n = 3). Statistical significance was determined using two-way ANOVA followed by Tukey's multiple comparisons test (M) Endothelial proliferation assay following SP1 silencing, COX-2 inhibition or p38 MAPK inhibition under TIMM44-overexpressing condition. Statistical significance calculated was assessed using two-tailed Student's t-tests *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. TIMM44-high tumour cells promote endothelial growth and proliferation. (A) Endothelial spheroid sprouting assay performed using conditioned media (CM) from control and TIMM44OE cells at CM:ECGM ratios of 25:75, 50:50, 75:25, and 100:0, ECGM alone was used as the baseline control, while IL-6 + ECGM served as a positive control. (B-E) Quantitative analysis of endothelial sprout number. For each CM:ECGM ratios, the number of endothelial spheroids analyzed (n) was as follows: 25:75 control (n = 7), TIMM44OE (n = 6); 50:50 control (n = 7), TIMM44OE (n = 10); 75:25 control (n = 4), TIMM44OE (n = 5); 100:0 control (n = 4), TIMM44OE (n = 5). (F-I) Quantitative analysis of average sprout length. The number of endothelial spheroids analyzed (n) for each CM:ECGM ratio was as follows; (average sprout length represents the mean value per spheroid) 25:75 control (n = 6), TIMM44OE (n = 6); 50:50 control (n = 7), TIMM44OE (n = 10); 75:25 control (n = 4), TIMM44OE (n = 4); 100:0 control (n = 2), TIMM44OE (n = 4). (J, K) Quantitative analysis of endothelial sprout diameter. The number of endothelial spheroids analyzed (n) was as follows; n = 5 (control) and 8 (TIMM44OE) for 50:50, and n = 3 (control) and 5 (TIMM44OE) for 100:0. Statistical significance of all quantifications, unless specifically mentioned, was assessed using two-tailed Student's t-tests comparing control and TIMM44OE independently for each CM:ECGM ratio (25:75, 50:50, 75:25, and 100:0). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (L) Endothelial cell proliferation assessed over a 5-day period following conditioned media treatment at the indicated ratios (n = 3). The sample with maximum growth rate was set at 100% and used for normalization of the rest (n = 3). Statistical significance was determined using two-way ANOVA followed by Tukey's multiple comparisons test (M) Endothelial proliferation assay following SP1 silencing, COX-2 inhibition or p38 MAPK inhibition under TIMM44-overexpressing condition. Statistical significance calculated was assessed using two-tailed Student's t-tests *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. To validate these effects in a more physiological setting, we used the chick chorioallantoic membrane (CAM) assay. Seventy-two hours after placing TIMM44OE or control cells onto the CAM, embryos receiving TIMM44-high cells showed a striking increase in vascular branching and density (Fig. S7A). The enhanced neovascularization observed in vivo closely mirrored the sprouting responses seen in vitro, reinforcing the idea that TIMM44 actively promotes an angiogenic tumor phenotype. Together, these results form a functional bridge between our molecular observations and physiological angiogenesis. Discussion Mitochondria are increasingly recognized as signalling hubs that integrate metabolic state with nuclear transcriptional programs [64]. Tumour angiogenesis can be initiated via distinct mechanisms and sprouting vessels are regarded as representative of pathological vascularization [1,65]. Although endothelial cells are not dependent on mitochondria for their energy requirements, these organelles serve as important biosynthetic and signalling entities that regulate the metabolism of endothelial cells, thereby affect the angiogenesis process [[65], [66], [67]]. In contrast, a rapidly proliferating tumour dynamically switches between glycolytic and OXPHOS states to fulfil their energy demands. The prevailing idea posits that induction of angiogenesis in OXPHOS-active tumours is primarily driven by intra-tumoural hypoxia, mainly driven by mtROS and metabolic byproducts such as lactate, which subsequently upregulate pro-angiogenic factors [26,68]. However, the specific mechanisms by which mitochondrial functional states are coupled with pro-angiogenic trigger from HIF-low tumour cells, remain incompletely understood. In this study, identify TIMM44-dependent mitochondrial remodelling as a proximal regulator of HIF-independent angiogenic signalling, suggesting that altered mitochondrial import and respiratory activity are not merely metabolic adaptations but active drivers of vascular reprogramming in tumour cells. Consistent with the stoichiometric organization of the TIM23-translocase complex [28,34,[69], [70], [71]], elevated TIMM44 drives coordinated activation of its associated components, resulting in enhanced mitochondrial protein import efficiency. This increase in import capacity reinforces mitochondrial gene expression and sustains elevated OXPHOS activity, enabling tumour cells to augment oxidative metabolism without a corresponding increase in mitochondrial mass, highlighting protein import efficiency as a limiting determinant of mitochondrial output. Despite no detectable increase in mitochondrial mass, TIMM44OE increased mtDNA copy number and enriched mitochondrial proteostasis and respiratory proteins, suggesting functional remodelling of the mitochondrial network rather than canonical mitochondrial biogenesis. The consequent increase in respiratory flux establishes a redox-competent state [72,73], that engages a non-canonical mechanism to drive endothelial proliferation. Our findings show that increased mitochondrial import capacity enhances respiratory chain remodelling and activates redox-sensitive ASK1-p38MAPK that ultimately culminates in SP1-dependent transcriptional upregulation of VEGFA (Fig. 7). Importantly, loss-of-function experiments demonstrate that elevated TIMM44 is required for activation of this non-canonical pro-angiogenic factors, indicating that mitochondrial import is not merely permissive but actively contributes to angiogenic response. Although TIMM44 was previously linked with endothelial proliferation [74], our study provides molecular insights into how, in tumour cells, TIMM44 links the mitochondrial import machinery to the transcriptional regulation of angiogenic factors.Fig. 7Schematic model of TIMM44-driven mitochondrial import-dependent angiogenic response. Increased mitochondrial remodelling mediated by TIMM44 facilitated mitochondrial protein import activates the ASK1-p38 MAPK axis, promoting HIF-alpha independent angiogenic responses. Schematic model of TIMM44-driven mitochondrial import-dependent angiogenic response. Increased mitochondrial remodelling mediated by TIMM44 facilitated mitochondrial protein import activates the ASK1-p38 MAPK axis, promoting HIF-alpha independent angiogenic responses. A key insight from our study is the distinction between abundance of active mitochondria (mitochondria biogenesis) and functional state of individual mitochondria. Induction of mitochondrial biogenesis through PGC-1α [75] resulted in increased active mitochondrial content, robustly induced HIF and VEGFA expression, but it failed to activate the ASK1-p38 axis. In contrast, elevated TIMM44 which enhances mitochondrial protein import and makes the organelle hyperactive, robustly activated these factors. These findings indicate that global oxidative metabolism due to increased mitochondrial content is not sufficient to drive this angiogenic response, and follows the canonical HIF-dependent induction of VEGFA [76]. TIMM44-mediated mitochondrial remodelling induced VEGFA expression in the absence of detectable HIF activation, through redox activated TRX-ASK1-p38-SP1 axis. The reduction of HIF-1α protein levels despite enhanced mitochondrial respiration and mtROS generation suggests that mitochondrial ROS alone is insufficient to stabilize HIF-1α. This suppression may involve a distinct metabolic state established by enhanced oxidative phosphorylation in TIMM44-remodelled mitochondria, which may alter intracellular oxygen distribution while maintaining sufficient localized oxygen availability for prolyl hydroxylases (PHDs), thereby permitting continued hydroxylation of HIF-1α and subsequent von Hippel–Lindau (VHL)-dependent ubiquitination and proteasomal degradation despite elevated respiratory activity [14,77]. Although this mechanism remains to be experimentally validated, it provides a plausible explanation for the uncoupling of mitochondrial redox signalling from canonical HIF-1α stabilization in TIMM44-overexpressing cells while allowing selective activation of the ASK1–p38–SP1 signalling axis. Our data support a model in which mitochondrial protein import defines a qualitatively distinct organelle state that is selectively coupled to downstream signalling pathways. However further exploration is required to identify the mediators sensing individual mitochondrial state and pan-enhancement of organellar biogenesis. The presence of this alternative mitochondrial retrograde pathway to sustain angiogenic output, potentially provides an adaptive advantage to highly proliferative tumours that exhibit metabolic reprogramming favouring oxidative phosphorylation and sustained biosynthesis to support rapid proliferation [[78], [79], [80]]. Beyond its mechanistic significance, our findings have important therapeutic implications. Although treatment of several angiogenesis-dependent malignancies has benefitted from anti-VEGF therapies, their clinical benefit is often transient owing to adaptive resistance, activation of compensatory pro-angiogenic pathways, and metabolic reprogramming that restores vascular support. Our study identifies TIMM44-dependent mitochondrial protein import as an upstream regulator of angiogenic signalling, thereby revealing a therapeutic vulnerability that lies proximal to VEGFA induction. Emerging evidence has implicated multiple components of the mitochondrial protein import machinery in tumour progression [[81], [82], [83], [84]], and our findings establish TIMM44 as the molecular link between mitochondrial proteostasis, respiratory metabolism, and HIF-independent angiogenic signalling. Consistent with this model, pharmacological inhibition of TIMM44 with MB-10 effectively suppressed VEGFA expression and attenuated the angiogenic phenotype, providing functional evidence that disruption of mitochondrial protein import can restrain tumour angiogenesis. As the scaffold protein that couples the presequence translocase-associated motor (PAM) to TIM23-translocase [[85], [86], [87]], TIMM44 occupies a central position in coordinating mitochondrial protein import, respiratory function, and redox signalling. Therapeutic targeting of TIMM44 could therefore, simultaneously compromise mitochondrial fitness and suppress angiogenic signalling, offering a mechanistically distinct strategy that may complement existing anti-VEGF therapies or help overcome resistance in metabolically active, OXPHOS-dependent tumours. However, there are several questions that remain to be addressed. How the system precisely distinguishes between the ROS-generated by TIMM44-remodelled mitochondria from generic enhancement of oxygen free-radicals to specifically activate ASK1 and no other redox-sensitive molecules such as PTEN, remains to be defined. It will be important to determine whether specific imported substrates or alterations in mitochondrial proteostasis contribute to this signalling event. Additionally, while our functional assays demonstrate pro-angiogenic activity in vitro and in the CAM model, further studies in mammalian tumour systems will be valuable to establish the in vivo relevance of TIMM44-dependent signalling in tumour progression. In summary, our findings identify mitochondrial protein import as a regulatory layer in organelle-to-nucleus communication that links mitochondrial remodelling to angiogenic transcription. By distinguishing mitochondrial import-dependent response from mitochondrial biogenesis-driven metabolic adaptation, this work provides a framework for understanding how qualitative changes in mitochondrial function can selectively influence tumour signalling networks. Materials and methods Cell lines and culture conditions Human breast cancer cell lines MCF-7, ZR-75-1, and T-47D were procured from the National Centre for Cell Science (NCCS), Pune, India. All cell lines used in this study were adherent and maintained under standard culture conditions. MCF-7 and ZR-75-1 cells were grown in Dulbecco's Modified Eagle Medium (DMEM; Gibco), whereas T-47D cells were cultured in RPMI (Gibco). Culture media were supplemented with 10% fetal bovine serum (FBS), and 100 U/mL penicillin. Cells were maintained at 37 °C in a humidified incubator with 5% CO2. For induction of mitochondrial biogenesis, cells were treated with 1% glycerol for 48 h to intrinsically upregulate PGC-1α, following which cells were harvested and whole-cell lysates were prepared for downstream analyses. A pcDNA3.1-based TIMM44 expression plasmid, obtained from GenScript, was used to establish stable TIMM44 overexpression cell lines. MCF-7, ZR-75-1, and T-47D cells were transfected with the TIMM44 construct and subjected to antibiotic selection using G418 (800 μg/mL). Individual resistant clones were isolated, expanded, and screened for TIMM44 overexpression by immunoblotting. Confirmed TIMM44OE clones were routinely maintained in growth medium containing 200 μg/mL G418 for all downstream experiments. For loss-of-function studies, shRNA-mediated knockdown of TIMM44 was performed by designing gene-specific shRNA oligonucleotides, which were cloned following standard Addgene protocols into pLKO.1 vector. Cells were subsequently transfected with the shRNA constructs and harvested after 72 h. Immunoblotting Total cellular protein lysates were prepared using ice-cold RIPA buffer supplemented with protease inhibitors and clarified by centrifugation at 12,000 rpm for 20 min at 4 °C. Protein concentrations were determined using the Bradford assay. Equal amounts of protein were mixed with Laemmli sample buffer containing 250 mM Tris-Cl (pH 6.8), 10% (w/v) SDS, 50% (v/v) glycerol, 1% (w/v) bromophenol blue, and 500 mM dithiothreitol, and denatured by heating at 95-100 °C for 10 min. Proteins were resolved by SDS-PAGE using gels of appropriate percentage and transferred onto PVDF membranes by wet transfer. Membranes were blocked with 5% (w/v) skimmed milk in TBST (Tris-buffered saline containing 0.1% Tween-20) for 1 h at room temperature and incubated with primary antibodies diluted in blocking buffer overnight at 4 °C with gentle agitation. After washing with TBST, membranes were incubated with HRP-conjugated secondary antibodies for 1-2 h at room temperature. Protein bands were detected using enhanced chemiluminescence (ECL) substrate (Biorad) and imaged using an Amersham Imager 360 or Vilber imaging system. Densitometric analysis was performed using ImageJ/Fiji software. In case of MB-10 treated samples, Coomassie stained post-transfer gels (CBB) was used as loading control since, MB-10 treatment was found to cause disruption in F-actin networks. The antibodies used are listed in Supplementary Table 1. RNA isolation Total RNA was isolated using the Qiagen RNeasy Mini Kit according to the manufacturer's instructions. Cells were lysed and homogenized, followed by the addition of 70% ethanol. Samples were loaded onto RNeasy silica spin columns and centrifuged. On-column DNase digestion was performed for 15 min. Columns were washed sequentially using the supplied buffers, and RNA was eluted in nuclease-free water. RNA concentration and purity were assessed using a NanoDrop spectrophotometer (Thermo Fisher Scientific). Quantitative real-time PCR analysis Gene expression analysis was performed by quantitative real-time PCR following reverse transcription of total RNA. Total RNA (1-5 μg) was mixed with random hexamer primers, incubated at 65 °C for 5 min, and cooled on ice. cDNA synthesis was carried out using reverse transcriptase (200 U), RNase inhibitor (20 U), dNTPs (10 mM), and 5× reaction buffer (Thermo Fisher Scientific) under the following conditions: 25 °C for 5 min, 42 °C for 60 min, and 70 °C for 10 min, followed by cooling at 4 °C. Quantitative PCR was performed using 0.2 μL of cDNA in reactions containing SYBR Green-based qPCR master mix (Puregene), gene-specific primers, and nuclease-free water. Amplification and fluorescence detection were carried out using a real-time PCR system (Quantstudio5) under optimized cycling conditions. Relative gene expression was calculated using the 2−ΔΔCt method, normalized to an appropriate endogenous control, and analyzed using GraphPad Prism. The primers used are listed in Supplementary Table 1. Spheroid sprouting assay Methylcellulose (Sigma) was prepared by dissolving 120 mg in 10 mL of endothelial cell growth medium (ECGM; PromoCell). HUVECs were harvested by trypsinization, resuspended in ECGM, and adjusted to a final density of 1000 cells per spheroid. The cell suspension was mixed with methylcellulose. Aliquots of 50 μL were dispensed onto uncoated 15 cm culture dishes, which were inverted to generate hanging drops and incubated overnight at 37 °C for spheroid formation. Following incubation, 25-50 spheroids per condition were collected and centrifuged to pellet the spheroids. A collagen matrix was prepared by mixing HEPES buffer (Himedia), 10× DMEM(Gibco), and collagen (Serva; 35040090) in a 1:1:8 ratio. After removal of the supernatant, 300 μL of the collagen mixture was added to the spheroid pellet, and spheroids were resuspended and plated into 48-well plates. After collagen polymerization, 300 μL of conditioned medium diluted in ECGM at 0%, 25%, 50%, and 100% was added to each well. Spheroid sprouting was monitored by phase-contrast microscopy. Image analysis was performed using ImageJ/Fiji, and graphical representation and statistical analysis were carried out using GraphPad Prism 8. CAM assay Fertilized chicken eggs were incubated at 37 °C under controlled humidity conditions to allow proper embryonic development. Formation of the chorioallantoic membrane (CAM) was observed by approximately day 3 of incubation. At this stage, a small window was carefully created in the eggshell to expose the CAM. A suspension containing 5000 cells mixed with basement membrane matrix (Sigma) was gently applied onto the CAM surface. The opening was subsequently sealed with parafilm, and the eggs were returned to the incubator and maintained at 37 °C to allow further development. Neovascularization in the CAM was monitored, and representative images were acquired 72 h after cell implantation. Estimation of mitochondrial superoxide levels Mitochondrial superoxide was measured using MitoSOX™ Red (Thermo Fisher Scientific). Cells were seeded at 3000 cells per well in 96-well plates and incubated for 24 h, followed by staining with 0.05 μM MitoSOX™ Red for 15 min at 37 °C. Cells were washed twice with 1× PBS and replaced with DMEM FluoroBrite. Fluorescence was recorded using a SpectraMax iD5 multimode reader at Ex 500 nm/Em 582 nm. Data were analyzed using GraphPad Prism 8. Assessment of mitochondrial membrane potential Mitochondrial membrane potential (ΔΨm) was measured using tetramethylrhodamine ethyl ester (TMRE; Thermo Fisher Scientific). Cells (2500 per well) were seeded in 96-well plates and cultured for 24 h. TMRE (0.05 μM) was added for 15 min at 37 °C, followed by three washes with 1× PBS and replacement with DMEM FluoroBrite. Fluorescence was recorded using a SpectraMax iD5 multimode reader at Ex 552 nm/Em 574 nm. Quantitative analysis was performed using GraphPad Prism 8. Determination of mitochondrial mass Mitochondrial mass was evaluated using 10-nonyl acridine orange (NAO; Thermo Fisher Scientific). Cells cultured in 96-well plates were incubated with NAO for 15 min at 37 °C under light-protected conditions. Following staining, cells were rinsed with 1× PBS, and DMEM FluoroBrite was added prior to fluorescence measurement. NAO fluorescence was measured using a SpectraMax iD5 multimode reader and analyzed using GraphPad Prism 8. Evaluation of mitochondrial morphology Mitochondrial morphology was examined using MitoTracker™ CMXROS (Thermo Fisher Scientific). Cells grown on coverslips were stained for 15 min at 37 °C, washed with 1× PBS, and mounted using ProLong™ Gold Antifade Mountant. High-resolution images were acquired using a Leica confocal microscope equipped with a 63× objective under identical acquisition settings. Images were processed using Adobe Photoshop 2021. Seahorse XF cell mito stress test Mitochondrial respiration was assessed using the Seahorse XF Cell Mito Stress Test Kit (Agilent) following the manufacturer's user guide. Seahorse XF sensor cartridges were hydrated overnight at 37 °C in a non-CO2 incubator. Cells were seeded at a density of 40,000 cells per well in Seahorse XF cell culture microplates and incubated overnight. On the day of the assay, Seahorse XF assay medium was prepared and supplemented with 10 mM glucose, 2 mM glutamine, and 1 mM sodium pyruvate. Growth medium was replaced with pre-warmed assay medium, and cells were incubated for 1 h at 37 °C in a non-CO2. Assay compounds were freshly prepared. Oligomycin (1.5 μM), FCCP (0.5 μM), rotenone (0.5 μM), and antimycin A (0.5 μM) were sequentially injected during the assay. Oxygen consumption rate (OCR) was measured using a Seahorse XF analyzer, and data were analyzed using Seahorse XF software. Graphs were generated and statistical analyses were performed using GraphPad Prism 8. Assessment of intracellular NAD+ and NADH levels Cellular NAD+ and NADH concentrations were quantified using the NAD/NADH-Glo™ Assay Kit (Promega; G9071, G9072) following the manufacturer's protocol. Cells were seeded in white, opaque 96-well plates and allowed to attach for 24 h. Prior to signal acquisition, cells were incubated with NAD/NADH-Glo™ detection reagent, with or without the reductase enzyme as required, for 5 min. Luminescence was recorded at 37 °C over a total period of 1 h, with 21 sequential measurements collected at 3-min intervals using a SpectraMax iD5 multimode reader (Molecular Devices). Luminescence values were processed and plotted using GraphPad Prism 8. Intracellular ATP quantification Cellular ATP content was assessed using the Mitochondrial ToxGlo™ ATP Assay (Promega; G8000). Cells were plated in 96-well formats and cultured under standard conditions (37 °C, 5% CO2). Twenty-four hours post-seeding, 20 μL of 5× cytotoxicity reagent was dispensed into each well, followed by gentle orbital agitation (500 rpm). Plates were incubated at 37 °C for 30 min prior to fluorescence acquisition at 485 nm excitation and 520-530 nm emission using a SpectraMax iD5 multimode reader. After fluorescence measurement, plates were allowed to equilibrate at room temperature for 5- 10 min. ATP detection reagent (100 μL) was then added to each well and mixed by orbital shaking (500 rpm). Luminescence signals were subsequently recorded using the SpectraMax iD5 over a 60-min period, with 21 consecutive readings collected at 3-min intervals. Measurement of respiratory chain complex activities The enzymatic activities of individual mitochondrial respiratory chain complexes were quantified using spectrophotometric assays with isolated mitochondria. For assessment of Complex I activity, mitochondria were permeabilized by incubation in phosphate buffer containing 1% deoxycholate (DOC) and 2 mM sodium azide for 15 min on ice. Following permeabilization, 1 mM NADH was added, and the reaction was initiated by supplementation with 60 μM ubiquinone. Complex I activity was determined by monitoring the rate of NADH oxidation, measured as a decrease in absorbance at 340 nm over a 2-min interval. Combined Complex I–III activity was measured using similarly permeabilized, sodium azide–treated mitochondria. In this assay, mitochondria were incubated with 1 mM NADH, and the reaction was triggered by the addition of 65 μM cytochrome c. The reduction of cytochrome c was followed spectrophotometrically as an increase in absorbance at 550 nm. Complex IV activity was determined by measuring the oxidation of reduced cytochrome c, monitored as a decline in absorbance at 550 nm. For all assays, parallel control reactions containing specific inhibitors of the respective complexes were performed to confirm assay specificity. Cell viability assay Cell viability was determined using the MTT assay (Thermo Fisher Scientific). Cells were seeded in 96-well plates and allowed to attach overnight. MTT reagent was added to each well at a final concentration of 0.5 mg/mL, and plates were incubated at 37 °C for 3-4 h. Formazan crystals were dissolved in dimethyl sulfoxide (DMSO), and absorbance was measured at 595 nm using a SpectraMax iD5 multimode reader. Cell viability was expressed as a percentage of the total cell population. Graphs were generated and statistical analyses were performed using GraphPad Prism 8. Mitochondrial DNA copy number analysis Mitochondrial DNA (mtDNA) copy number was determined by quantitative real-time PCR. Total genomic DNA was isolated using the Promega Wizard Genomic DNA Purification Kit according to the manufacturer's instructions. Quantitative PCR was performed using SYBR Green master mix with primers specific for the mitochondrial genes ND1 and CYTB, and the nuclear-encoded reference gene β-actin. Relative mtDNA copy number was calculated using the ΔCt method by normalizing mitochondrial gene Ct values to β-actin. Fold changes were expressed relative to control samples. Graphs were generated and statistical analyses were performed using GraphPad Prism 8. TCGA-based multi-platform analysis of TIMM44 expression and clinical associations Publicly available cancer genomics resources were systematically utilized to analyze TIMM44 expression, clinical relevance, survival outcomes, and genomic alterations across cancer types. Comparative expression analysis between tumor and normal tissues was performed using the TIMER2 web server, which integrates uniformly processed and batch-corrected RNA-sequencing data from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project. TIMM44 was queried through the gene expression module, and tumor-normal comparison box plots were generated directly using the TIMER2 visualization interface. Expression stratification according to tumor subclasses and pathological stage was carried out using UALCAN, which accesses TCGA level-3 RNA-seq data linked to curated clinical metadata; stage-wise and tumor subclasses expression plots were obtained using UALCAN's built-in plotting tools. Distribution of TIMM44 expression across different sample types (solid tissue normal, primary tumor, and metastatic samples), and grade-wise expression plots across multiple cancer types was further examined using the UCSC Xena by querying the TCGA Pan- Cancer (PANCAN) dataset, with TIMM44 selected as the genomic variable and clinical annotations used as phenotypic variables; box plots and bar charts were generated and exported directly from the Xena browser. Protein-level of TIMM44 were evaluated using immunohistochemical staining data obtained from the Human Protein Atlas, where representative images and qualitative expression summaries were retrieved. Violin plot–based expression analysis of TIMM44 across TCGA-BRCA sample types was performed using GEPIA2, which integrates TCGA and GTEx RNA-sequencing datasets normalized as transcripts per million (TPM); log2-transformed TPM values were used to generate violin plots via the GEPIA2 plotting module. Gene-gene correlation analysis involving TIMM44 was conducted using cBioPortal, utilizing Breast cancer invasive carcinoma TCGA firehose legacy (1896 samples)- mRNA expression data (RNA-seq, RSEM/TPM normalized); correlation coefficients (Pearson or Spearman, as implemented by the platform) were computed using the co-expression analysis module, and scatter plots depicting expression relationships were obtained directly from cBioPortal. Prognostic relevance of TIMM44 expression was assessed using overall survival analysis through the Kaplan-Meier Plotter, where patients were stratified into high- and low-expression groups based on median expression levels and survival curves were generated using the log-rank test. Genomic alteration analysis of TIMM44, including copy-number gains and deletions, was also performed using cBioPortal by querying the Breast cancer invasive carcinoma TCGA firehose legacy dataset, with alteration frequency summaries generated through the portal. All plots obtained from the respective platforms were exported and formatted uniformly for presentation. Mitochondrial proteome analysis Cells were harvested by trypsinization, washed with ice-cold PBS, and resuspended in hypotonic buffer, followed by incubation on ice for 30 min and mechanical disruption using a Dounce homogenizer (15 strokes). The homogenate was centrifuged at 600 × g for 15 min at 4 °C to remove nuclei and unbroken cells, and the supernatant was further centrifuged at 12,000 rpm for 20 min at 4 °C to obtain the mitochondrial pellet. Mitochondria were lysed in urea buffer (8 M urea, 75 mM NaCl, 1% SDS, 50 mM Tris-HCl pH 8.0, 1 mM MgCl2) supplemented with protease inhibitors, homogenized by pipetting, sonicated on ice (three 3-s pulses), and clarified by centrifugation at 12,000 rpm for 15 min at 4 °C. Proteins were precipitated using trichloroacetic acid (1:4, v/v) at −20 °C, collected by centrifugation at 12,000 rpm for 5 min, washed twice with ice-cold acetone, air-dried, and resuspended in RapiGest. Samples were resolved by SDS-PAGE, excised once migrated below the stacking gel, cut into ∼1 mm2 pieces, washed with 25 mM ammonium bicarbonate (ABC), and dehydrated using acetonitrile:ABC (2:1) until destained. Proteins were reduced with 10 mM dithiothreitol at 56 °C for 1 h, alkylated with 50 mM iodoacetamide for 30 min in the dark, dehydrated, and digested overnight at 37 °C using Trypsin/Lys-C in ABC. Peptides were sequentially extracted with 50%, 60%, and 80% acetonitrile containing 0.1% formic acid, pooled, dried by SpeedVac, and reconstituted in 0.1% formic acid for LC-MS/MS analysis. Samples were analyzed on a timsTOF Pro 2 mass spectrometer operated in data-independent acquisition mode, and raw data were processed using Bruker ProteoScape software. Downstream normalization, statistical analysis, and visualization were performed using MetaboAnalyst 6.0 and R (v4.5.2). Heatmaps were generated using pheatmap following log2 transformation and Z-score normalization of the top 100 most variable genes, with Euclidean distance–based hierarchical clustering. Differential expression analysis was conducted using log2 fold change and adjusted p-values, with significance defined as |log2FC| > 1 and padj < 0.05, and visualized using volcano plots generated with ggplot2 and ggrepel. KEGG pathway and Gene Ontology (Biological Process) enrichment analyses were performed using clusterProfiler with Benjamini-Hochberg correction (adjusted p < 0.05), and results were visualized using dot plots; all figures were exported at high resolution. Statistical analysis The sample size for each experiment is indicated in the corresponding figure and described in the figure legends. Unless otherwise stated, all data are representative of at least three independent biological experiments, and the number of biological replicates (n) is specified in the respective figure legends. Quantitative data are presented as the mean ± standard error of the mean (SEM). Error bars in all graphs represent the SEM. Statistical analyses were performed using GraphPad Prism 8. Comparisons between two groups were conducted using a two-tailed unpaired Student's t-test assuming equal standard deviations, unless otherwise stated. The statistical test used for each experiment is indicated in the corresponding figure legend. Statistical significance was determined by pairwise comparison with the appropriate control group. A P value < 0.05 was considered statistically significant and is denoted as. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. CRediT authorship contribution statement Tanvi Chaudhary: Writing – original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Sharath Mohan Bhat: Methodology, Investigation. Priyadarshika Pradhan: Methodology, Investigation. Manjunath B. Joshi: Validation, Project administration. Devanjan Sinha: Writing – review & editing, Validation, Supervision, Resources, Project administration, Funding acquisition, Conceptualization. Funding This work is supported by Department of Biotechnology grant (BT/PR53712/BMS/85/147/2024) and BHU-Institute of Eminence grant (R/Dev/IoE/Incentive/2021-22/32452) (to D.S.). The authors also acknowledge financial support UGC-CAS doctoral fellowship (to T.C.) and Raja-Jwala Prasad post-doctoral fellowship (to P.P.). The Open Access fees for this article is fully funded by the One Nation One Subscription (ONOS) initiative of Govt. of India (https://ror.org/036h6g940). Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.